BGEN celebrates record year following rebrand

BGEN is celebrating a record year following the company’s rebrand and has outlined ambitious targets for the year ahead. In the last financial year, turnover increased by more than 50% to £191m and the company has also reported a significant increase in operating profits.
“We’ve had an excellent year across the board, with significant growth achieved by our specialist pharmaceutical (BES) and food businesses (BFP),” says John Sugden, Executive Chair at BGEN. “